EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Obesity-related hypertension and chronic kidney disease: from evaluation to management

Mi-Hyang Jung, Sang-Hyun Ihm

Kidney Research and Clinical Practice · 31.07.2023 · 42 (4) · 431-444

DOI: 10.23876/j.krcp.23.072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, erschienen am 31.07.2023. Verfasst von Mi-Hyang Jung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Rep…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Disease Control and Prevention Agency, National Research Foundation of Korea, Chonnam National University Hospital Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the recent obesity pandemic, obesity-related hypertension and its complications (e.g., heart failure, coronary disease, and chronic kidney disease [CKD]) are gaining attention in clinical and research fields. Obesity-related hypertension frequently precedes the onset of CKD and aggravates its progression. In this review, we discuss the role of visceral fat in the pathophysiology of obesity-related hypertension and the potential therapeutic strategies for its prevention and management. Various factors, including the sympathetic nervous system, renin-angiotensin-aldosterone system, and inflammatory pathways, are intricately involved in the pathogenesis of obesity-related hypertension. These factors individually and jointly contribute to the development of hypertension (usually sodium-sensitive or resistant hypertension) and, ultimately, to the progression of CKD. From a clinical standpoint, a decline in renal function in advanced CKD further makes blood pressure control challenging since only a few options are available for blood pressure-lowering medications. Proactive lifestyle modification, pharmacological treatment for obesity, and bariatric surgery can be considered for obesity control and management. Furthermore, intensive blood pressure control is required to prevent and halt the development and progression of CKD.

Schlagwörter

Stichwörter der Autor:innen

Chronic renal insufficiencyHypertensionIntra-abdominal fatObesityRisk factorsSodium

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Cardiology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Förderung

  • Korea Disease Control and Prevention Agency
  • National Research Foundation of Korea
  • Chonnam National University Hospital Biomedical Research Institute

Zitieren

APA

Jung, M. H., & Ihm, S. H. (2023). Obesity-related hypertension and chronic kidney disease: from evaluation to management. Kidney Research and Clinical Practice, 42(4), 431-444. https://doi.org/10.23876/j.krcp.23.072

Vancouver

Jung MH, Ihm SH. Obesity-related hypertension and chronic kidney disease: from evaluation to management. Kidney Research and Clinical Practice. 2023;42(4):431-444. doi:10.23876/j.krcp.23.072

BibTeX
@article{Jung2023,
  author = {Jung, Mi-Hyang and Ihm, Sang-Hyun},
  title = {Obesity-related hypertension and chronic kidney disease: from evaluation to management},
  journal = {Kidney Research and Clinical Practice},
  year = {2023},
  volume = {42},
  number = {4},
  pages = {431--444},
  doi = {10.23876/j.krcp.23.072}
}
Kostenlos starten →